Report Detail
Global Biochips Sales Market (Sales,Revenue And Competitors Analysis Of Major Market) From 2014-2026
- RnM4087248 |
- 02 July, 2020 |
- Global |
- 106 Pages |
- XYZResearch |
- Pharma & Healthcare
According to XYZResearch study, over the next five years the Biochipsmarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in Biochipsbusiness.
Biochips market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
Sales forecast by type/application from 2021-2026
Industry chain, downstream and upstream information is also included.
Global markets continue to sink as the coronavirus spreads, reaching over 200 countries in total by the end of March. Now the outbreak continued to grow, as the number of cases in USA, Italy, Spain, Germany, France all spiked, Europe and USA have now become the epicenter of the outbreak, Cases in China appear have steadied in April, but there’s growing concern about the overall impact to the global market.
In China market, which experienced a difficult 2019 due to slowing domestic consumption and the impact of the Sino-US trade war, is once again facing more disruption and uncertainty at the hands of the coronavirus pandemic. Sales and consumption all fell in the first quarter of 2020, compared with the same period in 2019. The sales revenue of the major players will likely continue slowing in the 2nd quarter but in the second half of the year the fiscal and monetary policy would likely cause a strong rebound
In order to stop the spread of the COVID-19 outbreak, countries and world capital have been put under strict lockdown, bringing a total halt to major industrial production chains. It has caused supply chain disruptions for nearly three-quarters of U.S. companies, and in the second quarter, domestically consumption is likely to be hit even harder. The same situation also appeared in Europe, as the epidemic has required large-scale restrictions on the movement of people, investment, consumption and exports will all be strongly impacted by the epidemic, domestic production and consumption will plummet in the first half of 2020. We expected a U-shaped recovery in the second half of the year in USA and Europe market.
Brazil is already the hardest hit country in South America, many of these nations are still in the early stages of the virus’s proliferation. Infection levels have not yet peaked in April. South America 's market were on shaky ground even before the devastating impacts of the coronavirus, following a synchronized economic slowdown last year. China’s market downturn is impacting its trading partners in this region.
China, Japan, South Korea, India, and other Asia countries took the lead in introducing unprecedented measures to contain the virus, the market confidence in Asia-Pacific region is returning, EU and USA have relaxed its fiscal rules with maximum flexibility, this will stimulate the market demand in the second half of 2020.
Due to delays in the transport of components and raw materials, along with quarantine restrictions, the transportation of raw materials is affected, this will cause tight supply, and then the price of raw materials to rise. Meanwhile, as end-user demand weakens, many players are also facing the risk of higher inventory backlog, which may lead to passive production reduction, some traditional retailers began to develop the online business.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Biochips for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Global Biochips market competition by top manufacturers/players, with Biochips sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Affymetric Inc
Illumina Inc
GE Healthcare Ltd
Agilent Technologies Inc
Roche NimbleGen
Life Technologies Corporation
EMD Millipore
Bio-Rad Laboratories Inc
Abbott Laboratories
Fluidigm Corporation
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
DNA chips
Lab-on-a-chip
Protein chips
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Biochips for each application, including
Biotechnology
Genomics and proteomics
Drug screening and development
Molecular diagnostics
Microfluidic technologie
Microarray and biosensors
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Executive Summary
- 1.1 Definition and Specification
- 1.2 Report Overview
- 1.2.1 Manufacturers Overview
- 1.2.2 Regions Overview
- 1.2.3 Type Overview
- 1.2.4 Application Overview
- 1.3 Industrial Chain
- 1.3.1 Biochips Overall Industrial Chain
- 1.3.2 Upstream
- 1.3.3 Downstream
- 1.4 Industry Situation
- 1.4.1 Industrial Policy
- 1.4.2 Product Preference
- 1.4.3 Economic/Political Environment
- 1.5 SWOT Analysis
2 Market Analysis by Types
- 2.1 Overall Market Performance(Volume)
- 2.1.1 DNA chips
- 2.1.2 Lab-on-a-chip
- 2.1.3 Protein chips
- 2.2 Overall Market Performance(Value)
- 2.2.1 DNA chips
- 2.2.2 Lab-on-a-chip
- 2.2.3 Protein chips
3 Product Application Market
- 3.1 Overall Market Performance (Volume)
- 3.1.1 Biotechnology
- 3.1.2 Genomics and proteomics
- 3.1.3 Drug screening and development
- 3.1.4 Molecular diagnostics
- 3.1.5 Microfluidic technologie
- 3.1.6 Microarray and biosensors
4 Manufacturers Profiles/Analysis
- 4.1 Affymetric Inc
- 4.1.1 Affymetric Inc Profiles
- 4.1.2 Affymetric Inc Product Information
- 4.1.3 Affymetric Inc Biochips Sales, Sales Value(Million USD), Price and Gross Profit
- 4.1.4 Affymetric Inc SWOT Analysis
- 4.2 Illumina Inc
- 4.2.1 Illumina Inc Profiles
- 4.2.2 Illumina Inc Product Information
- 4.2.3 Illumina Inc BiochipsSales, Sales Value (Million USD), Price and Gross Profit
- 4.2.4 Illumina Inc SWOT Analysis
- 4.3 GE Healthcare Ltd
- 4.3.1 GE Healthcare Ltd Profiles
- 4.3.2 GE Healthcare Ltd Product Information
- 4.3.3 GE Healthcare Ltd BiochipsSales, Sales Value (Million USD), Price and Gross Profit
- 4.3.4 GE Healthcare Ltd SWOT Analysis
- 4.4 Agilent Technologies Inc
- 4.4.1 Agilent Technologies Inc Profiles
- 4.4.2 Agilent Technologies Inc Product Information
- 4.4.3 Agilent Technologies Inc BiochipsSales, Sales Value (Million USD), Price and Gross Profit
- 4.4.4 Agilent Technologies Inc SWOT Analysis
- 4.5 Roche NimbleGen
- 4.5.1 Roche NimbleGen Profiles
- 4.5.2 Roche NimbleGen Product Information
- 4.5.3 Roche NimbleGen BiochipsSales, Sales Value (Million USD), Price and Gross Profit
- 4.5.4 Roche NimbleGen SWOT Analysis
- 4.6 Life Technologies Corporation
- 4.6.1 Life Technologies Corporation Profiles
- 4.6.2 Life Technologies Corporation Product Information
- 4.6.3 Life Technologies Corporation BiochipsSales, Sales Value (Million USD), Price and Gross Profit
- 4.6.4 Life Technologies Corporation SWOT Analysis
- 4.7 EMD Millipore
- 4.7.1 EMD Millipore Profiles
- 4.7.2 EMD Millipore Product Information
- 4.7.3 EMD Millipore BiochipsSales, Sales Value (Million USD), Price and Gross Profit
- 4.7.4 EMD Millipore SWOT Analysis
- 4.8 Bio-Rad Laboratories Inc
- 4.8.1 Bio-Rad Laboratories Inc Profiles
- 4.8.2 Bio-Rad Laboratories Inc Product Information
- 4.8.3 Bio-Rad Laboratories Inc BiochipsSales, Sales Value (Million USD), Price and Gross Profit
- 4.8.4 Bio-Rad Laboratories Inc SWOT Analysis
- 4.9 Abbott Laboratories
- 4.9.1 Abbott Laboratories Profiles
- 4.9.2 Abbott Laboratories Product Information
- 4.9.3 Abbott Laboratories BiochipsSales, Sales Value (Million USD), Price and Gross Profit
- 4.9.4 Abbott Laboratories SWOT Analysis
- 4.10 Fluidigm Corporation
- 4.10.1 Fluidigm Corporation Profiles
- 4.10.2 Fluidigm Corporation Product Information
- 4.10.3 Fluidigm Corporation BiochipsSales, Sales Value (Million USD), Price and Gross Profit
- 4.10.4 Fluidigm Corporation SWOT Analysis
5 Market Performance for Manufacturers
- 5.1 Global Biochips Sales (K Units) and Market Share by Manufacturers 2014-2020
- 5.2 Global Biochips Revenue (M USD) and Market Share by Manufacturers 2014-2020
- 5.3 Global Biochips Price (USD/Unit) of Manufacturers 2014-2020
- 5.4 Global Biochips Gross Margin of Manufacturers 2014-2020
- 5.5 Market Concentration
6 Regions Market Performance for Manufacturers
- 6.1 China Market Performance for Manufacturers
- 6.1.1 China Biochips Sales (K Units) and Share of Manufacturers 2014-2020
- 6.1.2 China Biochips Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.1.3 China Biochips Price (USD/Unit) of Manufacturers 2014-2020
- 6.1.4 China Biochips Gross Margin of Manufacturers 2014-2020
- 6.1.5 Market Concentration
- 6.2 USA Market Performance for Manufacturers
- 6.2.1 USA Biochips Sales (K Units) and Share of Manufacturers 2014-2020
- 6.2.2 USA Biochips Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.2.3 USA Biochips Price (USD/Unit) of Manufacturers 2014-2020
- 6.2.4 USA Biochips Gross Margin of Manufacturers 2014-2020
- 6.2.5 Market Concentration
- 6.3 Europe Market Performance for Manufacturers
- 6.3.1 Europe Biochips Sales (K Units) and Share of Manufacturers 2014-2020
- 6.3.2 Europe Biochips Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.3.3 Europe Biochips Price (USD/Unit) of Manufacturers 2014-2020
- 6.3.4 Europe Biochips Gross Margin of Manufacturers 2014-2020
- 6.3.5 Market Concentration
- 6.4 Japan Market Performance for Manufacturers
- 6.4.1 Japan Biochips Sales (K Units) and Share of Manufacturers 2014-2020
- 6.4.2 Japan Biochips Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.4.3 Japan Biochips Price (USD/Unit) of Manufacturers 2014-2020
- 6.4.4 Japan Biochips Gross Margin of Manufacturers 2014-2020
- 6.4.5 Market Concentration
- 6.5 Korea Market Performance for Manufacturers
- 6.5.1 Korea Biochips Sales (K Units) and Share of Manufacturers 2014-2020
- 6.5.2 Korea Biochips Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.5.3 Korea Biochips Price (USD/Unit) of Manufacturers 2014-2020
- 6.5.4 Korea Biochips Gross Margin of Manufacturers 2014-2020
- 6.5.5 Market Concentration
- 6.6 India Market Performance for Manufacturers
- 6.6.1 India Biochips Sales (K Units) and Share of Manufacturers 2014-2020
- 6.6.2 India Biochips Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.6.3 India Biochips Price (USD/Unit) of Manufacturers 2014-2020
- 6.6.4 India Biochips Gross Margin of Manufacturers 2014-2020
- 6.6.5 Market Concentration
- 6.7 Southeast Asia Market Performance for Manufacturers
- 6.7.1 Southeast Asia Biochips Sales (K Units) and Share of Manufacturers 2014-2020
- 6.7.2 Southeast Asia Biochips Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.7.3 Southeast Asia Biochips Price (USD/Unit) of Manufacturers 2014-2020
- 6.7.4 Southeast Asia Biochips Gross Margin of Manufacturers 2014-2020
- 6.7.5 Market Concentration
- 6.8 South America Market Performance for Manufacturers
- 6.8.1 South America Biochips Sales (K Units) and Share of Manufacturers 2014-2020
- 6.8.2 South America Biochips Revenue (M USD) and Share of Manufacturers 2014-2020
- 6.8.3 South America Biochips Price (USD/Unit) of Manufacturers 2014-2020
- 6.8.4 South America Biochips Gross Margin of Manufacturers 2014-2020
- 6.8.5 Market Concentration
7 Global Biochips Market Assessment by Regions (2014-2020)
- 7.1 Global Biochips Sales (K Units) and Market Share by Regions 2014-2020
- 7.2 Global Biochips Revenue (M USD) and Market Share by Regions 2014-2020
- 7.3 Global Biochips Price (USD/Unit) by Regions 2014-2020
- 7.4 Global Biochips Gross Margin by Regions 2014-2020
8 Development Trend for Regions
- 8.1 Global Biochips Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.2 China Biochips Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.3 USA Biochips Sales and Growth, Sales Value and Growth Rate2014-2020
- 8.4 Europe Biochips Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.5 Japan Biochips Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.6 Korea Biochips Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.7 India Biochips Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.8 Southeast Asia Biochips Sales and Growth, Sales Value and Growth Rate 2014-2020
- 8.8 Southeast Asia Biochips Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
- 9.1 Upstream Source
- 9.2 Technology
- 9.3 Cost
10 Channel Analysis
- 10.1 Market Channel
- 10.2 Manufacturing Plants Distribution
11 Consumer Analysis
- 11.1 Biotechnology Industry
- 11.2 Genomics and proteomics Industry
- 11.3 Drug screening and development Industry
- 11.4 Molecular diagnostics Industry
- 11.5 Microfluidic technologie Industry
- 11.6 Microarray and biosensors Industry
12 Market Forecast 2021-2026
- 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
- 12.1.1 Global Biochips Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
- 12.1.2 Global Biochips Sales (K Units) and Growth Rate 2021-2026
- 12.1.3 China Biochips Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.4 USA Biochips Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.5 Europe Biochips Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.6 Japan Biochips Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.7 Korea Biochips Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.8 India Biochips Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.9 Southeast Asia Biochips Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.1.10 South America Biochips Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
- 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
- 12.2.1 Overall Market Performance
- 12.2.2 DNA chips
- 12.2.3 Lab-on-a-chip
- 12.2.4 Protein chips
- 12.3 Sales (K Units) Forecast by Application 2021-2026
- 12.3.1 Overall Market Performance
- 12.3.2 Biotechnology
- 12.3.3 Genomics and proteomics
- 12.3.4 Drug screening and development
- 12.3.5 Molecular diagnostics
- 12.3.6 Microfluidic technologie
- 12.3.7 Microarray and biosensors
- 12.4 Price (USD/Unit) and Gross Profit
- 12.4.1 Global Biochips Price (USD/Unit) Trend 2021-2026
- 12.4.2 Global Biochips Gross Profit Trend 2021-2026
13 Conclusion
Summary:
Get latest Market Research Reports on Biochips. Industry analysis & Market Report on Biochips is a syndicated market report, published as Global Biochips Sales Market (Sales,Revenue And Competitors Analysis Of Major Market) From 2014-2026. It is complete Research Study and Industry Analysis of Biochips market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
